BlueBlood Ventures Stock Forecast for 2023 - 2025 - 2030
Updated on 04/27/2024
BlueBlood Ventures Stock Forecast and Price Target
Based on the current earnings figures, this year's price targets for BlueBlood Ventures were recently set by distinguished experts, with an average mark of 0.00. If it reached this goal, it would represent a potential downside of approximately 0 from the previous closing price in October, 2021. The high end is 0.00, and the low is 0.00. If you're interested in investing in this company, why not also look at its competitors to see how they are doing?
N/A
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| RELIANCE Stock Forecast | Reliance Industries | Outperform |
10
|
Rp2.91k | Buy/Sell | Rp2.77k | 11.08% |
| HDFCBANK Stock Forecast | HDFC Bank | Buy |
8
|
Rp1.51k | Buy/Sell | Rp1.93k | 23.99% |
| INFY Stock Forecast | Infosys | Outperform |
10
|
Rp1.43k | Buy/Sell | Rp1.53k | 13.27% |
| 500696 Stock Forecast | Hindustan Unilever | Outperform |
10
|
Rp2.22k | Buy/Sell | Rp2.75k | 14.18% |
| 500010 Stock Forecast | Housing Development Finance Co... | - |
9
|
Rp2.73k | Buy/Sell | Rp3.23k | -42.32% |
BlueBlood Ventures Revenue Forecast for 2023 - 2025 - 2030
In the last three years, BlueBlood Ventures's Revenue has decreased by 90.51%, from 20.87M to 1.98M. Analysts predict that BlueBlood Ventures's Revenue will increase in the upcoming year, reaching 5.68M. This would represent an increase of 187.02%. Over the next seven years, experts predict that BlueBlood Ventures's Revenue will grow at a rate of 408.21%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 500510 Stock Forecast | Larsen & Toubro | Outperform |
8
|
Rp3.60k | Buy/Sell | Rp3.22k | 13.90% |
| BAJFINANCE Stock Forecast | Bajaj Finance | Outperform |
9
|
Rp6.73k | Buy/Sell | Rp8.56k | 28.21% |
| 500247 Stock Forecast | Kotak Mahindra Bank | Outperform |
9
|
Rp1.61k | Buy/Sell | Rp2.07k | 28.70% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 500570 Stock Forecast | Tata Motors | Outperform |
7
|
Rp999.35 | Buy/Sell | Rp814.72 | 1.37% |
| ONGC Stock Forecast | Oil and Natural Gas Corporatio... | Outperform |
4
|
Rp282.90 | Buy/Sell | Rp206.66 | -2.79% |
| 500114 Stock Forecast | Titan Company | Outperform |
7
|
Rp3.58k | Buy/Sell | Rp3.51k | 11.59% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| M&M Stock Forecast | Mahindra & Mahindra | Buy |
15
|
Rp2.04k | Buy/Sell | Rp1.71k | -1.46% |
| 500228 Stock Forecast | JSW Steel | Hold |
18
|
Rp886.60 | Buy/Sell | Rp775.93 | -3.00% |
| 500470 Stock Forecast | Tata Steel | Outperform |
18
|
Rp165.85 | Buy/Sell | Rp134.68 | -10.16% |
BlueBlood Ventures EBITDA Forecast for 2023 - 2025 - 2030
BlueBlood Ventures's EBITDA has grown in the last three years, jumping from -9.22M to 550.00k – an increase of 105.97%. According to 0 major analysts, BlueBlood Ventures's EBITDA will fall by 154.37% in the next year, reaching -299.04k. Professionals believe that By 2030, BlueBlood Ventures's EBITDA will fall to -1.50M– a 372.85% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SIEMENS Stock Forecast | Siemens | Outperform |
16
|
Rp5.75k | Buy/Sell | Rp4.02k | -15.51% |
| 500049 Stock Forecast | Bharat Electronics | Outperform |
16
|
Rp238.90 | Buy/Sell | Rp197.50 | -10.00% |
| 500188 Stock Forecast | Hindustan Zinc | Underperform |
18
|
Rp421.60 | Buy/Sell | Rp267.09 | -24.69% |
BlueBlood Ventures EBIT Forecast for 2023 - 2025 - 2030
In the last three years, BlueBlood Ventures's EBIT has increased by 102.03%, going from -9.34M to 190.00k. In the next year, 0 analysts estimate that BlueBlood Ventures's EBIT will decrease by 132.12%, reaching -61.03k. According to professional forecasts, in 2030, BlueBlood Ventures's EBIT will decrease by 419.33%, reaching -606.72k.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GRASIM Stock Forecast | Grasim Industries | Outperform |
17
|
Rp2.34k | Buy/Sell | Rp2.16k | 7.60% |
| 500425 Stock Forecast | Ambuja Cements | Hold |
18
|
Rp632.05 | Buy/Sell | Rp465.26 | -6.65% |
| PIDILITIND Stock Forecast | Pidilite Industries | Hold |
16
|
Rp2.98k | Buy/Sell | Rp2.55k | -6.96% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| VEDL Stock Forecast | Vedanta | Hold |
17
|
Rp396.55 | Buy/Sell | Rp256.85 | -3.54% |
| 500400 Stock Forecast | The Tata Power Company | Hold |
18
|
Rp436.75 | Buy/Sell | Rp245.44 | -26.27% |
| 500440 Stock Forecast | Hindalco Industries | Outperform |
18
|
Rp649.55 | Buy/Sell | Rp556.54 | -6.86% |
.jpg)